Cambridge Trust CO Amgen Inc Transaction History
Cambridge Trust CO
- $2.6 Billion
- Q1 2024
A detailed history of Cambridge Trust CO transactions in Amgen Inc stock. As of the latest transaction made, Cambridge Trust CO holds 3,427 shares of AMGN stock, worth $993,487. This represents 0.04% of its overall portfolio holdings.
Number of Shares
3,427
Previous 3,770
9.1%
Holding current value
$993,487
Previous $1.09 Million
10.23%
% of portfolio
0.04%
Previous 0.05%
Shares
28 transactions
Others Institutions Holding AMGN
# of Institutions
3,122Shares Held
410MCall Options Held
7.56MPut Options Held
7.2M-
Vanguard Group Inc Valley Forge, PA52.4MShares$15.2 Billion0.31% of portfolio
-
Black Rock Inc. New York, NY46MShares$13.3 Billion0.33% of portfolio
-
State Street Corp Boston, MA29.3MShares$8.5 Billion0.39% of portfolio
-
Morgan Stanley New York, NY14.7MShares$4.26 Billion0.35% of portfolio
-
Primecap Management CO Pasadena, CA14.3MShares$4.13 Billion3.44% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $155B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...